Cardiac resynchronisation therapy (CRT) is common treatment for congestive heart failure
(HF) with decreased LV function and wide QRS complex. Its foundations are set in the …

Cardiac resynchronization therapy (CRT) is currently an established device therapy for heart
failure (HF) patients. Cumulated knowledge on the pathophysiological mechanisms …

More than 2 decades of research has established the role of cardiac resynchronization
therapy (CRT) in medically refractory, mild to severe systolic heart failure (HF) with abnormal …

Cardiac resynchronisation therapy (CRT) is an effective treatment for patients with advanced
heart failure (HF), New York Heart Association class (NYHA) III or IV, a reduced left …

Cardiac resynchronization therapy (CRT) is currently an established device therapy for heart
failure (HF) patients. Existing knowledge of implantation techniques, advances in device …

Cardiac resynchronisation therapy (CRT) is an effective intervention for appropriately
selected patients with heart failure, but exactly how it works is uncertain. Recent data …

Heart failure (HF) is a critical health issue. Despite the advancements in pharmacotherapy,
HF-related morbidity and mortality remains high. Cardiac resynchronization therapy (CRT) …

This is the first part of a two‐part series on strategies for optimizing the delivery of cardiac
resynchronization therapy (CRT), focusing on device‐related aspects. There is …

Cardiac resynchronization therapy (CRT) has revolutionized the care of the patients with
heart failure with reduced ejection fraction and electrical dyssynchrony. The current …

Cardiac resynchronization therapy (CRT) based on biventricular pacing (BVP) is an
invaluable intervention currently used in heart failure (HF) patients. The therapy involves …